Dosage and usage of garadacimab-ANDEMBRY

Garadacimab-ANDEMBRY is a medicine used to prevent attacks of hereditary angioedema (HAE) in adults and children 12 years of age and older. Its usage and dosage are designed to ensure effective and safe treatment for patients.

1. Recommended dose: The recommended dose of gadaximab is an initial loading dose of 400 mg administered subcutaneously on the first day of treatment. This is usually divided into two injections of 200 mg each. After that, patients need to receive maintenance dose injections of 200 mg every month to ensure continued preventive effects.

2. Treatment of missed doses: If a dose of gadaximab is missed, the dose should be replenished as soon as possible. If a patient fails to get their injection within the ideal time, action should be taken as soon as possible to maintain the continuity and effectiveness of treatment.

3. Administration preparation and technique: Gadaximab is only for subcutaneous use. Patients can choose to self-administer the drug or have it injected by a nursing staff. Patients and caregivers need to be educated on the proper preparation and subcutaneous administration techniques of gadaximab before treatment is initiated. Before administration, gadaximab needs to be taken out of the refrigerator and left at room temperature for about 30 minutes to ensure that the drug temperature is appropriate.

During the injection, gadaximab should be injected subcutaneously into the thigh or abdomen, making sure the injection site is 1 inch (approximately 2 centimeters) from the belly button. Nursing staff can also choose the upper arm as the injection site when administering subcutaneous injections. Used syringes and needles should be properly disposed of in a dedicated sharps disposal container for safety.

In short, the usage and dosage of gadaximab are reasonably designed to provide patients with a safe and effective treatment option. Patients should follow the recommended dosage and administration methods during use, and communicate with their medical provider in a timely manner when necessary to ensure the best therapeutic effect.

Reference materials:https://www.andembryhcp.com/